Description
LGD-3303 research SARM
LGD-3303 is a non-steroidal SARM developed by Ligand Pharmaceuticals and studied in preclinical bone and muscle models.
Product details
| Compound | LGD-3303 |
|---|---|
| Class | Selective androgen receptor modulator |
| Form | Tablets; Liquid; Capsules |
| Strength | 30ct / 12mg per tablet / 360mg; 60ct / 12mg per tablet / 720mg; 30ml / 17mg per ml / 500mg; 30ml/33mg per ml/1000mg; 20mg per capsule/60ct/1.2g; 15ml/17mg per ml/250mg |
| Labelling | Compound name and strength on every container |
Select your format and strength from the options above.
What LGD-3303 research has examined
- Bone research: rat osteoporosis models.
- Tissue selectivity.
- Comparative research: versus LGD-4033.
Learn more in What are SARMs?
Regulatory status
LGD-3303 is not an approved medicine. The FDA has warned about serious risks from products containing SARMs and similar compounds, and these compounds are prohibited in sport by WADA. Supplied as a research chemical only.
Storage and handling
Keep the container tightly closed, at room temperature or cooler, away from moisture and light.
Related research products
ACP 105 · Ligandrol (LGD-4033) · RAD 140 (Testolone) · All SARMs
References
For laboratory research use only. Not for human or animal consumption. Not intended to diagnose, treat, cure or prevent any disease.
Reviews
There are no reviews yet.